MSI
57
5
SHW
58
2
DGX
46
3
BLK
69
5
PNW
53
3
NOV
40
-2
L
51
2
MRK
45
2
O
35
2
PCG
50
5
IR
63
-3
HES
54
-2
HSIC
45
-2
NAVI
49
2
AON
62
2
CNP
62
12
PPL
57
-2
NEE
54
-11
NRG
55
-4
FDX
48
-2
MSI
57
5
SHW
58
2
DGX
46
3
BLK
69
5
PNW
53
3
NOV
40
-2
L
51
2
MRK
45
2
O
35
2
PCG
50
5
IR
63
-3
HES
54
-2
HSIC
45
-2
NAVI
49
2
AON
62
2
CNP
62
12
PPL
57
-2
NEE
54
-11
NRG
55
-4
FDX
48
-2
Financhill
Buy
64

ALNY Quote, Financials, Valuation and Earnings

Last price:
$324.76
Seasonality move :
8.35%
Day range:
$311.26 - $323.41
52-week range:
$205.87 - $333.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
17.67x
P/B ratio:
364.63x
Volume:
1.2M
Avg. volume:
859.5K
1-year change:
29.21%
Market cap:
$42.1B
Revenue:
$2.2B
EPS (TTM):
-$2.09

Alnylam Pharmaceuticals SEC Filings

Company Filed Form Type Description
ALNY
Alnylam Pharmaceuticals
 05/02/2024 10-Q 10-Q filing on 05/02/2024 View Form
ALNY
Alnylam Pharmaceuticals
 11/02/2023 10-Q 10-Q filing on 11/02/2023 View Form
ALNY
Alnylam Pharmaceuticals
 08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
ALNY
Alnylam Pharmaceuticals
 10/27/2022 10-Q 10-Q filing on 10/27/2022 View Form
ALNY
Alnylam Pharmaceuticals
 07/28/2022 10-Q 10-Q filing on 07/28/2022 View Form
ALNY
Alnylam Pharmaceuticals
 04/28/2022 10-Q 10-Q filing on 04/28/2022 View Form
ALNY
Alnylam Pharmaceuticals
 10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
ALNY
Alnylam Pharmaceuticals
 08/03/2021 10-Q 10-Q filing on 08/03/2021 View Form
ALNY
Alnylam Pharmaceuticals
 04/29/2021 10-Q 10-Q filing on 04/29/2021 View Form
ALNY
Alnylam Pharmaceuticals
 02/11/2021 10-K 10-K filing on 02/11/2021 View Form
ALNY
Alnylam Pharmaceuticals
 11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ALNY
Alnylam Pharmaceuticals
 08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
ALNY
Alnylam Pharmaceuticals
 05/06/2020 10-Q 10-Q filing on 05/06/2020 View Form
ALNY
Alnylam Pharmaceuticals
 02/13/2020 10-K 10-K filing on 02/13/2020 View Form
ALNY
Alnylam Pharmaceuticals
 10/31/2019 10-Q 10-Q filing on 10/31/2019 View Form
ALNY
Alnylam Pharmaceuticals
 08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
ALNY
Alnylam Pharmaceuticals
 05/02/2019 10-Q 10-Q filing on 05/02/2019 View Form
ALNY
Alnylam Pharmaceuticals
 02/14/2019 10-K 10-K filing on 02/14/2019 View Form
ALNY
Alnylam Pharmaceuticals
 11/07/2018 10-Q 10-Q filing on 11/07/2018 View Form
ALNY
Alnylam Pharmaceuticals
 08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2018 10-Q 10-Q filing on 05/04/2018 View Form
ALNY
Alnylam Pharmaceuticals
 02/15/2018 10-K 10-K filing on 02/15/2018 View Form
ALNY
Alnylam Pharmaceuticals
 11/07/2017 10-Q 10-Q filing on 11/07/2017 View Form
ALNY
Alnylam Pharmaceuticals
 08/09/2017 10-Q 10-Q filing on 08/09/2017 View Form
ALNY
Alnylam Pharmaceuticals
 05/05/2017 10-Q 10-Q filing on 05/05/2017 View Form
ALNY
Alnylam Pharmaceuticals
 02/15/2017 10-K 10-K filing on 02/15/2017 View Form
ALNY
Alnylam Pharmaceuticals
 11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
ALNY
Alnylam Pharmaceuticals
 08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
ALNY
Alnylam Pharmaceuticals
 02/12/2016 10-K 10-K filing on 02/12/2016 View Form
ALNY
Alnylam Pharmaceuticals
 11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
ALNY
Alnylam Pharmaceuticals
 08/07/2015 10-Q 10-Q filing on 08/07/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Related Companies

Get ALNY Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

ALNY
Sector
P/E ratio
--
23.88x
PEG ratio
--
0.00x
P/B ratio
364.63x
1.80x
Price / LTM sales
17.67x
1.65x

Growth Metrics

ALNY
Sector
Revenue growth
20.2%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
59.22%
8.01%
Earnings forecast
$0.07
-$0.20

Profitability

ALNY
Sector
Profitability FY 2024
$1.9B
$47.5M
Return on invested capital
-26.39%
-16.26%
Return on assets
-6.58%
-13.27%
Return on equity
--
-18.61%

Earnings Date

Last Earnings Date
May
1
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Jul
31

Balance Sheet

ALNY
Sector
Total cash
$2.6B
$35.5M
Short term investments
$1.7B
$29.7M
Total assets
$4.2B
$106.9M
Long term debt
$1B
$7.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Read article
Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Read article
Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Read article

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy or Sell?
Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Buy or Sell?
Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Buy or Sell?

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy or Sell?
Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy or Sell?
Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector